Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E1912 Trial

Blood (2019) 134 (Supplement_1): 33.

https://doi.org/10.1182/blood-2019-126824

Published: 2019

Journal Articles

Developmental DNA Methylation Subtype Predicts Progression to Treatment and Survival in High-Count Monoclonal B Lymphocytosis

Brian Giacopelli, BS, Kari G. Chaffee, MS, Yue-zhong Wu, MSc, John C. Byrd, MD, Tait D. Shanafelt, MD, Sameer A. Parikh, MD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Christopher C. Oakes, PhD

Blood (2019) 134 (Supplement_1): 3022.

https://doi.org/10.1182/blood-2019-123564

Published: 2019

Journal Articles

Quiescence/Mobilization of Hematopoietic Immature Cells Induced By Polyphenols through Modulation of APC/EPCR/PAR-1 Axis

Cristiane Okuda Torello, PhD, Erich V De Paula, MD PhD, Rodrigo Naoto Shiraishi, PhDstudent, Santos Irene, PhD, Fernanda I Della Via, MSc, Mariana Pissarra, training/fellow, Marisa Claudia Alvarez De Prax, PhD, Mary L. S. Queiroz, MD PhD, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 4996.

https://doi.org/10.1182/blood-2019-127354

Published: 2019

Journal Articles

Epigallocatechin-3-Gallate Induces Cellular Differentiation and Reduces Leukemia Burden in PML/Rarα Mice By Increasing Reactive Oxygen Species and Reducing PIN1 Expression

Fernanda I Della Via, MSc, Rodrigo Naoto Shiraishi, PhDstudent, Santos Irene, PhD, Karla P Ferro, PhD, Myriam Salazar-Terreros, PhDMSc, Gilberto C Franchi Junior, Eduardo M Rego, MD PhD, Sara T Olalla Saad, PhD, Cristiane Okuda Torello, PhD

Blood (2019) 134 (Supplement_1): 5765.

https://doi.org/10.1182/blood-2019-130542

Published: 2019

Journal Articles

Polyphenols Modulate Quiescence/Mobilization of Hematopoietic Immature Cells through APC/EPCR/PAR-1 Axis

Cristiane O Torello, PhD, Erich Vinicius De Paula, MD PhD, Rodrigo Naoto Shiraishi, training/fellow, Tamara C. Lopes de Castro, undergraduate, Fernanda Martins, PhD, Fernanda I Della Via, PhDstudent, Marisa Claudia Alvarez De Prax, PhD, Mary L. S. Queiroz, MD PhD, Sara T. Olalla Saad, MD PhD

Blood (2018) 132 (Supplement 1): 3830.

https://doi.org/10.1182/blood-2018-99-114902

Published: 2018

Journal Articles

Elucidating the Non-Catalytic Function of Fatty Acid Synthase and Its Autophagy-Dependent Degradation in Acute Myelocytic Leukemia Differentiation Therapy

Magali Humbert, PhD, Severin Mosimann, Vreni Rentsch, Mario P. Tschan, PhD

Blood (2018) 132 (Supplement 1): 2624.

https://doi.org/10.1182/blood-2018-99-112068

Published: 2018

Journal Articles

ROS Production Triggers Anti-Leukemic Effects of Green Tea

Cristiane Okuda Torello, PhD, Rodrigo Naoto Shiraishi, Fernanda Isabel Della Via, Mary L S Queiroz, MD PhD, Sara Teresinha Olalla Saad, MD PhD, Eduardo Magalhaes Rego, PhD

Blood (2016) 128 (22): 5219.

https://doi.org/10.1182/blood.V128.22.5219.5219

Published: 2016

Journal Articles

Epicatechin Impact on Primary Hemostasis, Coagulation and Fibrinolysis

Thomas Sinegre, PharmD, André Mazur, PhD, Marc G Berger, MD PhD Professor, Dragan Milenkovic, PhD, Anne-Françoise Sapin, Christine Morand, PhD, Aurelien Lebreton, MD PhD

Blood (2015) 126 (23): 4677.

https://doi.org/10.1182/blood.V126.23.4677.4677

Published: 2015

Journal Articles

Green Tea In Acute Myeloid Leukemia

Andrana Calgarotto, PhD, Fernando V Pericole, MD, Patricia Favaro, PhD, Victor Maso, Gilberto Franchi, Jr, Alexandre Nowill, PhD, José Vassallo, MD, PhD, Paulo Latuf Filho, Mary L. Souza Queiroz, Sara T O Saad, MD, PhD

Blood (2013) 122 (21): 5032.

https://doi.org/10.1182/blood.V122.21.5032.5032

Published: 2013

Journal Articles

Green Tea Extract EGCG Induces Apoptosis in CLL Cells and Overcomes the Supportive Effect of Primary Bone Marrow Stromal Cells Through the Regulation of PI3K/Akt Cascade and Proteasome Activity

Elena Ponath, Susanne Schnabl, Martin Hilgarth, Dita Demirtas, Marlies Reiter, Eva Fuchs, Rainer Hubmann, Ulrich Jäger, Medhat Shehata

Blood (2012) 120 (21): 3916.

https://doi.org/10.1182/blood.V120.21.3916.3916

Published: 2012

Journal Articles

A Phase II Trial of TBL 12 Sea Cucumber Extract in Patients with Untreated Asymptomatic Myeloma,

Ajai Chari, MD, Amitabha Mazumder, MD, Lauren Ditrio, Zachary Galitzeck, Sundar Jagannath, MD

Blood (2011) 118 (21): 3992.

https://doi.org/10.1182/blood.V118.21.3992.3992

Published: 2011

Journal Articles

A Phase II Trial of TBL 12 Sea Cucumber Extract In Patients Withuntreated Asymptomatic Myeloma

Amitabha Mazumder, MD, Ajai Chari, MD, Lauren Ditrio, Zachary Galitzeck, Sundar Jagannath, MD

Blood (2010) 116 (21): 5042.

https://doi.org/10.1182/blood.V116.21.5042.5042

Published: 2010

Journal Articles

Striking Anti-Multiple Myeloma (MM) Activity with the In Vitro Use of the Multikinase Inhibitor Sorafenib (S), Cytotoxic Synergy Between Bortezomib (B) and S, but Not Between B and Epigallocatechin-3-Gallate (EGCG; E) Enlarge the Present Knowledge In MM and Promise Novel Insights for Innovative Substance Exploitation In MM-Treatment

Josefina Udi, Dagmar Wider, Julie Catusse, Gabriele Ihorst, Dominik Schnerch, Marie Follo, Meike Burger, Ralph M. Waesch, MD, Monika Engelhardt

Blood (2010) 116 (21): 5020.

https://doi.org/10.1182/blood.V116.21.5020.5020

Published: 2010

Journal Articles

Stromal Rescue of Drug Exposed CLL Cells Can Be Overcome by the Green Tea Extract Epigallocatechin 3 Gallate

Connie 1Lesnick, Neil E. Kay, Betsy LaPlant, Tait Shanafelt, MD

Blood (2010) 116 (21): 3610.

https://doi.org/10.1182/blood.V116.21.3610.3610

Published: 2010

Journal Articles

The Green Tea Extract EGCG Demonstrates Synergist Activity against CLL B-Cells When Combined with Fludarabine and Chlorambucil.

Connie Lesnick, Neil E. Kay, MD, Betsy LaPlant, Tait D. Shanafelt, M.D.,

Blood (2009) 114 (22): 3452.

https://doi.org/10.1182/blood.V114.22.3452.3452

Published: 2009

Journal Articles

In Vitro Assessment of Anti-Multiple Myeloma (MM)-Agents On Various MM-Cell Lines (MMCLs) with Use of Bortezomib, Sorafenib, Thalidomide, Lenalidomide and EpiGalloCatechin-3-Gallate (EGCG) Demonstrates to Be a Valuable Tool for the Thorough Analysis and Discovery of Innovative Anti-MM-Agents.

Josefina Udi, Dagmar Wider, Gabriele Ihorst, Julia Schüler, Ralph Wäsch, Monika Engelhardt

Blood (2009) 114 (22): 4922.

https://doi.org/10.1182/blood.V114.22.4922.4922

Published: 2009

Journal Articles

Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid–based proteasome inhibitors

Encouse B. Golden, Philip Y. Lam, Adel Kardosh, Kevin J. Gaffney, Enrique Cadenas, Stan G. Louie, Nicos A. Petasis, Thomas C. Chen, Axel H. Schönthal

Blood (2009) 113 (23): 5927–5937.

https://doi.org/10.1182/blood-2008-07-171389

Published: 2009

Journal Articles

Bortezomib and EGCG: no green tea for you?

Jatin J. Shah, Deborah J. Kuhn, Robert Z. Orlowski

Blood (2009) 113 (23): 5695–5696.

https://doi.org/10.1182/blood-2009-03-204776

Published: 2009

Journal Articles

Potential Synergism of Green Tea and Aspirin as a Possible Cause of Bleeding in a Diabetic

Roger C Munro, PhD, Lisa J Wakeman, MSc, Saad Al-Ismail

Blood (2008) 112 (11): 4504.

https://doi.org/10.1182/blood.V112.11.4504.4504

Published: 2008

Journal Articles

Green Tea Catechin Epigallocatechin-3-Gallate (EGCG) Induces Cell Death in Acute Myeloid Leukemic Cells Via DAPK2 and Potentiates ATRA-Induced Neutrophil Differentiation

Adrian Britschgi, MSc, Hans-Uwe Simon, MD, PhD, Andreas Tobler, MD, Martin F. Fey, MD, Mario P. Tschan, PhD

Blood (2008) 112 (11): 2628.

https://doi.org/10.1182/blood.V112.11.2628.2628

Published: 2008

NARROW

Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E1912 Trial

Developmental DNA Methylation Subtype Predicts Progression to Treatment and Survival in High-Count Monoclonal B Lymphocytosis

Quiescence/Mobilization of Hematopoietic Immature Cells Induced By Polyphenols through Modulation of APC/EPCR/PAR-1 Axis

Epigallocatechin-3-Gallate Induces Cellular Differentiation and Reduces Leukemia Burden in PML/Rarα Mice By Increasing Reactive Oxygen Species and Reducing PIN1 Expression

Polyphenols Modulate Quiescence/Mobilization of Hematopoietic Immature Cells through APC/EPCR/PAR-1 Axis

Elucidating the Non-Catalytic Function of Fatty Acid Synthase and Its Autophagy-Dependent Degradation in Acute Myelocytic Leukemia Differentiation Therapy

ROS Production Triggers Anti-Leukemic Effects of Green Tea

Epicatechin Impact on Primary Hemostasis, Coagulation and Fibrinolysis

Green Tea In Acute Myeloid Leukemia

Green Tea Extract EGCG Induces Apoptosis in CLL Cells and Overcomes the Supportive Effect of Primary Bone Marrow Stromal Cells Through the Regulation of PI3K/Akt Cascade and Proteasome Activity

A Phase II Trial of TBL 12 Sea Cucumber Extract in Patients with Untreated Asymptomatic Myeloma,

A Phase II Trial of TBL 12 Sea Cucumber Extract In Patients Withuntreated Asymptomatic Myeloma

Stromal Rescue of Drug Exposed CLL Cells Can Be Overcome by the Green Tea Extract Epigallocatechin 3 Gallate

The Green Tea Extract EGCG Demonstrates Synergist Activity against CLL B-Cells When Combined with Fludarabine and Chlorambucil.

In Vitro Assessment of Anti-Multiple Myeloma (MM)-Agents On Various MM-Cell Lines (MMCLs) with Use of Bortezomib, Sorafenib, Thalidomide, Lenalidomide and EpiGalloCatechin-3-Gallate (EGCG) Demonstrates to Be a Valuable Tool for the Thorough Analysis and Discovery of Innovative Anti-MM-Agents.

Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid–based proteasome inhibitors

Bortezomib and EGCG: no green tea for you?

Potential Synergism of Green Tea and Aspirin as a Possible Cause of Bleeding in a Diabetic

Green Tea Catechin Epigallocatechin-3-Gallate (EGCG) Induces Cell Death in Acute Myeloid Leukemic Cells Via DAPK2 and Potentiates ATRA-Induced Neutrophil Differentiation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only